Bayer | BAYN - Ebitda


Bayer reported EUR4.45B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Air Liquide EUR 3.82B 205.4M Dec/2025
Akzo Nobel EUR 345M 540M Mar/2026
Alcon AG USD 795M 478M Mar/2026
Amarin USD 12.54M 28.57M Jun/2025
Arkema EUR 282.7M 208.7M Mar/2026
AstraZeneca USD 5.67B 1.29B Mar/2026
BASF EUR 2.36B 217M Mar/2026
Bayer EUR 4.45B 2.49B Mar/2026
Beiersdorf EUR 984M 147M Jun/2025
Corteva USD 1.44B 992M Mar/2026
Covestro EUR 117M 125M Dec/2025
Essilor EUR 3.09B 356M Dec/2024
Fresenius EUR 951M 283M Mar/2026
Fresenius Medical Care EUR 824M 250M Mar/2026
Genmab DKK 186M 291M Dec/2025
Givaudan CHF 778M 195M Dec/2025
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
GRIFOLS EUR 347.45M 210K Dec/2025
Henkel EUR 1.88B 139M Dec/2024
Hikma Pharmaceutical USD 369M 84M Dec/2024
Johnson Matthey GBP 325M 52M Jun/2024
Linde USD 3.44B 59M Mar/2026
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.53B 87M Mar/2026
Novartis USD 5.3B 530M Mar/2026
Nutrien USD 1.1B 172M Mar/2026
Philips EUR 567M 233M Mar/2026
PPG Industries USD 596M 163M Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 3.31B 3.65B Mar/2026
SAP EUR 3.17B 606M Mar/2026
Solvay EUR 219M 50M Mar/2026
UCB EUR 1.6B 570M Dec/2025
Umicore EUR 414M 19M Dec/2025
Vinci EUR 7.83B 1.7B Dec/2025